about
Thyroid receptor ligands. 6. A high affinity "direct antagonist" selective for the thyroid hormone receptorToward a benchmarking data set able to evaluate ligand- and structure-based virtual screening using public HTS data.Identification of a novel scaffold for allosteric inhibition of wild type and drug resistant HIV-1 reverse transcriptase by fragment library screening.Discovery of pyrazinone based compounds that potently inhibit the drug-resistant enzyme variant R155K of the hepatitis C virus NS3 protease.Design, synthesis and in vitro biological evaluation of oligopeptides targeting E. coli type I signal peptidase (LepB).Docking of Macrocycles: Comparing Rigid and Flexible Docking in Glide.Regio- and Stereoselective Synthesis of Functionalized Cyclopentene Derivatives via Mizoroki-Heck Reactions.Selective Synthesis of Spirooxindoles by an Intramolecular Heck-Mizoroki Reaction.Mechanistic aspects of transition metal-catalyzed hydrogen transfer reactions.Iron chelators target both proliferating and quiescent cancer cells.Is benzene oxide homoaromatic? A microcalorimetric study.Kinetic and thermodynamic stability of naphthalene oxide and related compounds. A comparative microcalorimetric and computational (DFT) study.Deconstruction of non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1 for exploration of the optimization landscape of fragments.Mechanistic insights into the phosphine-free RuCp*-diamine-catalyzed hydrogenation of aryl ketones: experimental and theoretical evidence for an alcohol-mediated dihydrogen activation.Asymmetric hydrogenation of trisubstituted olefins with iridium-phosphine thiazole complexes: a further investigation of the ligand structure.Synthesis of 11C-Labelled Ureas by Palladium(II)-Mediated Oxidative Carbonylation.Route to 3-Amidino Indoles via Pd(II)-Catalyzed C-H Bond Activation.Pan-NS3 protease inhibitors of hepatitis C virus based on an R3-elongated pyrazinone scaffold.Boronic ester-linked macrocyclic lipopeptides as serine protease inhibitors targeting Escherichia coli type I signal peptidaseRationally Designed Ligands for Asymmetric Iridium-Catalyzed Hydrogenation of OlefinsPreclinical Characterization of Acyl Sulfonimidamides: Potential Carboxylic Acid Bioisosteres with Tunable PropertiesRemote dipole effects as a means to accelerate [Ru(amino alcohol)]-catalyzed transfer hydrogenation of ketonesA theoretical investigation into the inversion barrier of dipole-stabilized alpha-aminoorganolithiumsMolecular Mechanics (MM3) Parameters for Ruthenium(II)-Polypyridyl ComplexesNew mechanistic insights into the iridium-phosphanooxazoline-catalyzed hydrogenation of unfunctionalized olefins: a DFT and kinetic studyA DFT-derived model predicts solvation-dependent configurational stability of organolithium compounds: a case study of a chiral alpha-thioallyllithium compoundThyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinityOrigin of enantioselectivity in the Ru(arene)(amino alcohol)-catalyzed transfer hydrogenation of ketonesSmall kinase assay panels can provide a measure of selectivityConformational analysis of macrocycles: comparing general and specialized methods
P50
Q27643236-7A874D84-3548-488C-B754-45DE13BB30F4Q30883069-309A3DE5-FF78-4CAA-80AE-82DA380C5E7BQ33786075-FE74F7FA-99F4-4644-B78E-BCDBB9AA9A50Q36012511-6FCDF4BA-CD4D-41E0-93ED-FA412DE4BC2CQ36236707-0749051E-BA3C-4FD0-9460-C9B1E0C8E4ECQ36247137-274A21FC-F7E5-49B8-B387-D887A68E9446Q36307065-A1FABC26-58C2-40AE-9E27-173F28A28CD3Q36362864-CF55ACFC-23CC-42D7-9515-A81D7CA5DDA4Q36408494-584BA8AA-9844-499C-ADE7-63D333B0C5E5Q37479772-0936F759-8C6C-4D2F-93F8-547539EAA005Q43768637-B497878D-8167-4BCF-B2CA-831D4613D320Q44193069-4B1745F9-584E-4429-9360-613072E8FE73Q45370048-47153097-B5D3-4550-89B0-E71E59F6122BQ46773981-6E96C760-F328-4742-A624-4C608AABB6EDQ46967679-9BC8E089-EEF4-43F8-8FB6-7FBBDA6DEC74Q48216578-81619030-0D22-42E4-9A87-E7D7135480CDQ52564855-A74B8881-3002-4274-9F4D-A17EE55EFB50Q54267237-D131607B-53A1-469D-AB31-AC5A25BE7804Q60921300-2B1BD019-A76E-480B-81FC-4A2FF02C152FQ61930836-02DC80E7-AD77-4F76-81D6-4797C8D35A6BQ64027819-44761752-356F-42E4-B7F5-8C4C2BFEC5AFQ73824360-20EFBCFF-FA9B-4D69-B4B3-3D2FB1F496E0Q74243344-3F424F30-F4BA-4248-B667-C58A0711BAAEQ74831876-623A3F7C-693F-4B99-B295-91B7A35ECEB7Q78729753-3468B3C7-92F8-4CAA-B3EB-9E482BD33D51Q78756738-EF757EFF-E4BF-4DDA-818A-76DC1BCE9CFFQ79664851-BA8D95BD-8797-4E71-AA0C-93560C62EF68Q80344657-96D8630A-D320-4B60-B736-1369B70DBCDFQ84550022-1038BED7-F058-4160-A276-4C266B0BCE13Q92829689-6ABF93EE-EB3A-4251-8B07-30626920F06D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter Brandt
@ast
Peter Brandt
@en
Peter Brandt
@es
Peter Brandt
@nl
type
label
Peter Brandt
@ast
Peter Brandt
@en
Peter Brandt
@es
Peter Brandt
@nl
prefLabel
Peter Brandt
@ast
Peter Brandt
@en
Peter Brandt
@es
Peter Brandt
@nl
P106
P1153
57032158300
P31
P496
0000-0002-2885-2016